Mechanistic insights into the ameliorative effects of Xianglianhuazhuo formula on chronic atrophic gastritis through ferroptosis mediated by YY1/miR-320a/TFRC signal pathway
机构:[1]Department of Spleen and Stomach Diseases, First Affiliated Hospital of Hebei University of Chinese Medicine, Shijiazhuang, Heibei, 050011, China.[2]Hebei Key Laboratory of Integrated Chinese and Western Medicine for Gastroenterology Research, First Affiliated Hospital of Hebei University of Chinese Medicine, Shijiazhuang, Hebei, 050011, China[3]Hebei Key Laboratory of Turbidity Toxin Syndrome, First Affiliated Hospital of Hebei University of Chinese Medicine, Shijiazhuang, Hebei, 050011, China.[4]College of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, Heibei, 050200, China.
This study was supported by the Construction Project of National Clinical Research Base of Traditional Chinese Medicine (Science Letter [2018] No. 131, State Office of Traditional Chinese Medicine); Natural Science Foundation of Hebei Province (No. H2023423001); Key Research Project of the Ministry of Science and Technology (No. 2018YFC1704100, 2018YFC1704102); Provincial Science and Technology Program of Hebei Province (No. 21377724D; 21377740D); and Scientific Research Project of Hebei Administration of Traditional Chinese Medicine (No. 2021034, 2022026, 2022032, 2023022).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类|2 区医学
小类|1 区全科医学与补充医学1 区药学2 区药物化学2 区植物科学
最新[2025]版:
大类|2 区医学
小类|1 区全科医学与补充医学1 区药学2 区药物化学2 区植物科学
第一作者:
第一作者机构:[1]Department of Spleen and Stomach Diseases, First Affiliated Hospital of Hebei University of Chinese Medicine, Shijiazhuang, Heibei, 050011, China.
共同第一作者:
通讯作者:
通讯机构:[1]Department of Spleen and Stomach Diseases, First Affiliated Hospital of Hebei University of Chinese Medicine, Shijiazhuang, Heibei, 050011, China.[2]Hebei Key Laboratory of Integrated Chinese and Western Medicine for Gastroenterology Research, First Affiliated Hospital of Hebei University of Chinese Medicine, Shijiazhuang, Hebei, 050011, China[3]Hebei Key Laboratory of Turbidity Toxin Syndrome, First Affiliated Hospital of Hebei University of Chinese Medicine, Shijiazhuang, Hebei, 050011, China.
推荐引用方式(GB/T 7714):
Guo Yuxi,Jia Xuemei,Du Pengli,et al.Mechanistic insights into the ameliorative effects of Xianglianhuazhuo formula on chronic atrophic gastritis through ferroptosis mediated by YY1/miR-320a/TFRC signal pathway[J].Journal Of Ethnopharmacology.2023,323:117608.doi:10.1016/j.jep.2023.117608.
APA:
Guo Yuxi,Jia Xuemei,Du Pengli,Wang Jie,Du Yao...&Yang Qian.(2023).Mechanistic insights into the ameliorative effects of Xianglianhuazhuo formula on chronic atrophic gastritis through ferroptosis mediated by YY1/miR-320a/TFRC signal pathway.Journal Of Ethnopharmacology,323,
MLA:
Guo Yuxi,et al."Mechanistic insights into the ameliorative effects of Xianglianhuazhuo formula on chronic atrophic gastritis through ferroptosis mediated by YY1/miR-320a/TFRC signal pathway".Journal Of Ethnopharmacology 323.(2023):117608